Press release
Seasonal Affective Disorder Therapeutics Market CAGR Projected for 4.3% by 2028 | Allergan plc., Eli Lily Company, GlaxoSmithKline plc, Pfizer Inc., Teva Pharmaceuticals Inc., Bausch Health Companies Inc.
Popular drugs preferred in seasonal affective disorder therapeutics include selective serotonin reuptake inhibitors (SSRIs), according to the report. While generics and branded drugs are widely available in seasonal affective disorder therapeutics market, Buproban and Citalopram continue to register relatively higher sales. FMI attributes this dominance to high availability of generic versions of the aforementioned drugs.
Request to View Sample of Research Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-8821
Bright light therapy that has been the most preferred line of treatment in seasonal affective disorder therapeutics continues to receive strong support from physicians and patients owing to positive end results. While more than half the sales of devices used in seasonal affective disorder therapeutics is accounted by light boxes, sales of desk lamps are also thriving at a brisk rate.
A highly recommended prophylactic measure involved in seasonal affective disorder therapeutics, light therapy is characterized by its rapid, reliable, and highly anti-depressant action. Extensive adoption of bright light therapy by the patients afflicted by a sub-syndromal disease and self-reporting patient population prompts at bolstered revenue visibility prospected for seasonal affective disorder treatment therapeutics in coming years.
Demand for Combination Therapy for SAD Picking Up
The report opines that light therapy is the first line of treatment that seasonal affective disorder therapeutics providers opt for. However, a possible ineffective outcome for certain patients of SAD related psychiatric illnesses and depression creates scope of combination therapies. Some of the recently reported clinical trials emphasize potential efficacy of combination of light therapy, psychotherapy, talk therapy, and antidepressants in seasonal affective disorder therapeutics.
Inaccessibility at workplaces or during traveling has been a shortfall of light box therapy over the years. To help patients suffering from SAD explore non-conventional alternatives to seasonal affective disorder therapeutics, Austria-based med-tech startup, Active Wearables, recently launched a wearable device – Pocket Sky – providing light therapy, practically anywhere. The wearable has a wireless charging feature and the battery life is claimed to last for a couple of weeks. The Pocket Sky will potentially serve as a portable and lightweight light therapy solution to patients of seasonal affective disorder. Such innovations will continue to innovate the seasonal affective disorder therapeutics market landscape.
Request for a Customization of This Report @ https://www.futuremarketinsights.com/customization-available/rep-gb-8821
Inadequate availability of research data and ineffective documentation, especially related to use of bright light and blue light in light therapy, is posing a long-term challenge to rapid revenue growth of seasonal affective disorder therapeutics market. Moreover, proven adversities associated with excessive use of antidepressants also remain a concern among physicians and patients alike, limiting healthy growth prospects of seasonal affective disorder therapeutics market.
The report tracks performance of global seasonal affective therapeutics market over 2018-2028. In-depth strategic profiles of some of the leading players have been covered in the report, including Allergan plc, Eli Lily Company, GlaxoSmithKline plc, Pfizer Inc., Teva Pharmaceuticals Inc., F. Hoffmann-La Roche AG, Sanofi AG, Novartis AG, Janssen Pharmaceuticals, Inc., and Koninklijke Philips N.V. among others.
Seasonal Affective Disorder Therapeutics Market Reports - Table of Contents
1. Executive Summary
Global Market Outlook
Analysis and Recommendations
2. Market Overview
Market Coverage / Taxonomy
Market Definition / Scope / Limitations
3. Market Background
Macro-Economic Factors
Forecast Factors - Relevance & Impact
Market Dynamics
Drivers
Restraints
Opportunities
Trends
4. Key Success Factors
Key Regulations
Disease Epidemiology
5. Global Seasonal Affective Disorder Therapeutics Market Volume Analysis 2013-2017 and Forecast, 2018-2028
Historical Market Volume (‘000 Units) Analysis, 2013-2017
Current and Future Market Volume (‘000 Units) Projections, 2018-2028
6. Global Seasonal Affective Disorder Therapeutics Market - Pricing Analysis
Regional Pricing Analysis By Device Type
Global Average Pricing Analysis Benchmark
7. Global Seasonal Affective Disorder Therapeutics Market Value Analysis 2013-2017 and Forecast, 2018-2028
Historical Market Value (US$ Mn) Analysis, 2013-2017
Current and Future Market Value (US$ Mn) Projections, 2018-2028
Y-o-Y Growth Trend Analysis
Absolute $ Opportunity Analysis
8. Global Seasonal Affective Disorder Therapeutics Market Analysis 2013-2017 and Forecast 2018-2028, by Treatment Type
Introduction / Key Findings
Historical Market Size (US$ Mn) Analysis By Treatment Type, 2013 - 2017
Current and Future Market Size (US$ Mn) Analysis and Forecast By Treatment Type, 2018 – 2018
Drugs
Selective serotonin reuptake inhibitors (SSRIs)
Norepinephrine-dopamine reuptake inhibitor (NDRI)
Serotonin and norepinephrine reuptake inhibitors (SNRIs)
Monoamine oxidase inhibitors (MAOIs)
Tricyclic antidepressants (TCAs)
Devices
Light Boxes
Dawn Stimulators
Desk Lamps
Sun Visors
Market Attractiveness Analysis By Treatment Type
Browse Full Report @ https://www.futuremarketinsights.com/reports/seasonal-affective-disorder-therapeutics-market
About Us
Future Market Insights is the premier provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in London, the global financial capital, and has delivery centers in the U.S. and India.
FMI’s research and consulting services help businesses around the globe navigate the challenges in a rapidly evolving marketplace with confidence and clarity. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. We continuously track emerging trends and events in a broad range of end industries to ensure our clients prepare for the evolving needs of their consumers.
Contact Us
U.S. Office
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
F: +1-845-579-5705
Email: sales@futuremarketinsights.com
Blog: http://keepfacts.com/
Web: https://www.futuremarketinsights.com/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Seasonal Affective Disorder Therapeutics Market CAGR Projected for 4.3% by 2028 | Allergan plc., Eli Lily Company, GlaxoSmithKline plc, Pfizer Inc., Teva Pharmaceuticals Inc., Bausch Health Companies Inc. here
News-ID: 1756460 • Views: …
More Releases from Future Market Insights
AI in IoT Market Set to Reach USD 172.8 Billion by 2035 with 6.4% CAGR Amid Risi …
The AI in IoT market is witnessing rapid expansion as enterprises across industries increasingly integrate artificial intelligence with Internet of Things (IoT) systems. Valued at USD 92.9 billion in 2025, the market is projected to reach USD 172.8 billion by 2035, representing a compound annual growth rate of 6.4%. The integration of AI into IoT infrastructure enables predictive analytics, real-time monitoring, and automated control across multiple applications, transforming how businesses…
Catalog Management System Market Poised to Reach USD 4.2 Billion by 2035 with Ad …
The catalog management system (CMS) market is experiencing steady and strategic growth, with its value projected to rise from USD 1.9 billion in 2025 to USD 4.2 billion by 2035, reflecting a compound annual growth rate (CAGR) of 8.1%. The market expansion is primarily fueled by businesses' growing need for centralized product information, streamlined digital operations, and enhanced customer experiences across increasingly complex sales channels.
As e-commerce continues to penetrate global…
HIFI Electronics Market Set to Double by 2035, Driven by Premium Audio and Techn …
The global HIFI electronics market is poised for remarkable growth over the next decade, projected to expand from USD 17,243.4 million in 2025 to USD 37,227.2 million by 2035. This impressive growth trajectory, representing an absolute increase of nearly USD 19,983.8 million and a compound annual growth rate (CAGR) of 8%, reflects the rising global appetite for premium audio experiences and high-fidelity sound reproduction across personal and professional applications.
The expansion…
Interrogation Table Market to Reach USD 435.7 Million by 2035, Driven by Securit …
The global interrogation table market, valued at USD 321.1 million in 2025, is set to grow steadily to USD 435.7 million by 2035, registering a moderate CAGR of 3.1%. This trajectory reflects a market gradually approaching maturity, where incremental demand for specialized security furniture outweighs rapid expansion. The early stage from 2025 to 2028 is expected to see modest increases in annual revenues, primarily linked to new infrastructure development across…
More Releases for Seasonal
5 Seasonal Realism Hoodie Trends Popular Now
Relaxed tailoring is everywhere this season. Blazers hang loose with softer lines. Pants flow easy without sharp creases. Comfort meets structure in perfect balance. Oversized suits rule both work events. Wide-legged trousers make a smooth return. Boxy jackets layer over fine shirts. It's elegance made effortless and modern. Traditional cuts get a fresh edit. Tailored pieces now feel light and airy. Structured shoulders soften with natural movement. Casual realism hoodie…
Maximizing HVAC Efficiency During Seasonal Transitions
Seasonal transitions can be a bit of a rollercoaster, right? One day it's chilly enough to need a blanket, the next it's warm enough to consider cranking up the AC. Your HVAC system gets a serious workout during these times, and if it's not prepared, you could be left with uneven temperatures, high energy bills, or worse-an unexpected breakdown.
But don't worry, we've got your back. With just a few simple…
Protecting Hicksville Homes from Seasonal Pest Infestations
Seasonal changes often bring a surge in pest activity, making it crucial for homeowners in Hicksville to stay vigilant. Different pests become more active depending on the time of year, posing risks to both the comfort and safety of homes. At Majestic Pest Control - Hicksville Exterminator Service, we understand the challenges these infestations present and offer tailored solutions to protect local properties effectively.
Here's an in-depth look at the types…
Tips to Triumph over Seasonal Allergies
Allergy season has arrived and brought with it a haze of pollen and allergens, leaving millions of affected individuals longing for relief. The health experts at Envolve, an integrated healthcare solutions company, have put together a few tips to help you proactively manage your exposure and response to allergens and allergy triggers – and help you get through allergy season more comfortably.
Consider allergy testing. Consult your primary care provider (PCP)…
Nordics Countries Seasonal Influenza Vaccine Market
Nordics Seasonal Influenza Vaccine Market Forecast in (Denmark, Finland, Iceland, Norway & Sweden) By (Child & Adult) Vaccination report published by Renub Research. According to this report, Sweden is having the highest seasonal influenza vaccine market share. In terms of children vaccination, Sweden & Denmark hold nearly 70 percent market share in 2016 whereas, in adult vaccination segments, these two will share more than 60 percent market share by 2022.
This…
Seasonal Influenza Vaccination Market in Baltic Countries
Seasonal Influenza Vaccination Market in Lithuania, Estonia, Latvia (Baltic Countries) By (Child & Adult) Forecast report published by Renub Research. According to this report, in the Baltic Countries, Lithuania is having the highest seasonal influenza vaccine market share followed by Latvia and Estonia. In terms of children vaccination, Lithuania & Latvia hold nearly 70 percent market share in 2016 whereas, in adult vaccination segments, these two will share more than…
